Joint Corp Stock Price, News & Analysis

The Joint Corp. (NASDAQ: JYNT) has acquired four franchised clinics for $5.8 million, effective May 19, 2022. This strategic acquisition enhances the company's corporate portfolio in the Scottsdale/Phoenix area, aligning with its growth strategy. CEO Peter D. Holt noted that these high-performing clinics will be immediately accretive to earnings and enhance operating margins. The valuation is consistent with prior acquisitions, reflecting the strength of the clinic teams. The acquisition bolsters The Joint's position as the largest chiropractic provider in the nation, with over 700 locations and nearly 11 million patient visits annually.

The Joint Corp. (NASDAQ: JYNT), the largest chiropractic care provider in the U.S., announced participation in several investor conferences in May and June 2022. Key events include the B. Riley 22nd Annual Institutional Investor Conference on May 25, the Craig-Hallum Annual Conference on June 1, the Stifel 2022 Cross Sector Insight Conference on June 9, and the Oppenheimer 22nd Annual Consumer Growth & E-Commerce Conference on June 14. The company will conduct presentations and one-on-one meetings, with materials available on their Investor Relations website.

The Joint Corp. (JYNT) reported strong growth in Q1 2022, with revenue increasing 28% to $22.4 million and system-wide sales up 27% to $98.8 million compared to Q1 2021. Despite a net loss of $206,000, the company opened 31 clinics, achieving a total of 736 clinics, including 100 corporate clinics. Adjusted EBITDA decreased to $1.8 million from $3.5 million, influenced by rising labor costs and operational expenses. The company updated its 2022 revenue guidance to $98-102 million, affirming its target of 110-130 new franchised clinics.

The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care, will release its first quarter 2022 financial results on May 5, 2022, after market close. CEO Peter D. Holt and CFO Jake Singleton will host a conference call at 5:00 p.m. ET to discuss the results. Interested participants can listen via phone at (765) 507-2604 or (844) 464-3931 using code 5175957. A live webcast and slide presentation will be available on the company's investor relations site and can be accessed for one year. The Joint Corp. operates over 700 clinics nationwide.

The Joint Corp. (NASDAQ: JYNT) announced the acquisition of regional developer rights for Northern California for $2.4 million, effective April 1, 2022. This acquisition allows oversight of 56 franchised clinics, including 20 operational and 36 in development, plus the opportunity for 19 more clinics. CEO Peter D. Holt stated this move aims to enhance growth and margin contribution in California, signaling strategic expansion potential in the chiropractic care market.

The Joint Corp. (NASDAQ: JYNT) announced the acquisition of the regional developer territory for Northern New Jersey, encompassing four franchised clinics, for $250,000 on March 17, 2022. This strategic move aims to bolster their corporate clinic footprint in the Northeast and aligns with their goal of opening 1,000 clinics by the end of 2023. As of the announcement, they operate 99 clinics, having added three new locations since December 2021.

The Joint Corp. (NASDAQ: JYNT) announced participation in key investor events. The Maxim Group LLC 2022 Virtual Growth Conference will take place from March 28-30, featuring President and CEO Peter D. Holt and CFO Jake Singleton. The event will include a live presentation on March 28, available on demand. Additionally, Holt will participate in the SEC’s 41st Annual Small Business Forum on April 7, focusing on capital raising policy. The Joint is the largest provider of chiropractic care in the U.S., with over 700 locations and nearly 11 million patient visits annually.

The Joint Corp. (NASDAQ: JYNT), the largest provider of chiropractic care in the U.S., announced management's upcoming presentations at key conferences in March 2022. The schedule includes:

• March 10: D.A. Davidson 5th Annual Consumer Growth Conference at 1:15 PM PT / 4:15 PM ET (Virtual format).
• March 14-15: 34th Annual Roth Conference (In-person 1x1 meetings).

Presentation materials will be available on their Investor Relations website. The company continues to lead with over 700 locations and nearly 11 million patient visits annually.

The Joint Corp. (NASDAQ: JYNT) reported robust financial results for 2021, with revenue growth of 38% year-over-year, totaling $81.2 million. System-wide sales increased 39% to $361.1 million, driven by 706 clinics in operation by year-end. Quarterly results for Q4 2021 showed revenue rise to $22.4 million, a 32% increase from Q4 2020. However, net income dipped to $224,000 from $10.6 million a year prior. Looking ahead, the company anticipates 2022 revenue between $102 million and $106 million, indicating continued growth potential.